EQS-News: LataMed AI to Submit Forward Stock Split Request to FINRA as Company Advances Operational Expansion Strategy EQS-News: LataMed AI Corp. to Attend Meditech Colombia 2026 as Company Advances Latin American Commercialization Strategy EQS-News: LataMed AI Corp. to Begin Trading Under Symbol LMED Following FINRA Approval EQS-News: LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED EQS-News: Catalyst Crew Technologies Provides Update on Share Cancellation Initiative and Corporate Name Change EQS-News: Catalyst Crew Technologies Announces Receipt of Venezuelan Health Authority Approval for Telehealth Platform Operations EQS-News: Catalyst Crew Technologies Establishes LataMed AI VE, C.A. to Support Venezuelan Telehealth Operations EQS-News: Catalyst Crew Technologies Provides Capital Structure Update Regarding CEO Equity Restructuring Initiative EQS-News: Catalyst Crew Technologies to Attend HLTH Europe 2026 EQS-News: Catalyst Crew Technologies Provides Update on Regulatory and Initial Deployment Activities for Telehealth Platform in Venezuela EQS-News: Catalyst Crew Technologies Appoints Vilma Casanova as Chief Operating Officer EQS-News: Catalyst Crew Technologies Announces Initial Launch of Telehealth Platform EQS-News: Catalyst Crew Technologies Provides Update on Telehealth Platform Development EQS-News: Catalyst Crew Technologies Announces Assignment of Venezuelan Patents to Wholly-Owned Subsidiary and Outlines Global IP Strategy EQS-News: Catalyst Crew Technologies Introduces NeuroAI, an AI-Driven Platform for Neurological Analysis and Predictive Risk Modeling